Pune’s Serum institute carries out Phase 3 Clinical trials of Covid 19 Vaccine

Square

 

A Vaccine developed by Pune’s Serum institute is currently being tested at Pune’s Naidu Hospital, on Sunday. The vaccine is being tested along with an Ayurvedic formula. The vaccine has been developed with the help of the American company Kodagenix and Serum is carrying out phase 3 clinical trials of the vaccine, as per reports.

On April 27, Serum Institute of India (SII) – one of largest producers of vaccines in the world revealed that it will begin work on the production of the COVID-19 vaccine which has been developed by Oxford University within 2-3 weeks. The Pune-based firm revealed that if clinical trials of the vaccine are successful then the COVID vaccine would be out in the market by October. Over 800 healthy volunteers have been recruited for the study being injected with ChAdOx1 nCoV-19, making this the sixth coronavirus vaccine to enter the first phase of clinical trials.

But, recent reports reveal that the University of Oxford’s experimental vaccine has only a 50 percent chance of success, as stated by Adrian Hill, one of the professors heading the program. As per reports, Oxford’s Jenner institute is developing a potential vaccine with a pharmaceutical company AstraZeneca Plc, which is being considered as one of the front-runners in the global race to provide a shield against the deadly disease. The work on the vaccine started in early January a day after scientists decoded the genomes of the virus, which much faster than any other vaccine development program took place in history.